BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

2353

543264

NURECA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NURECA LIMITED performance

Today’s low

Today’s high

₹ 281.50 ₹ 291.00
₹ 286.65

52 week low

52 week high

₹ 203.62 ₹ 447.50
₹ 286.65

Open Price

₹ 289.90

Prev. Close

₹ 289.90

Volume (Shares)

7918.00

Total traded value

₹ 22.69

Upper Circuit

₹ 304.35

Lower Circuit

₹ 275.40

info

NURECA LIMITED Share Price Update

As of the latest trading session, NURECA LIMITED share price is currently at ₹ 286.9, which is down by ₹ -3.00 from its previous closing. Today, the stock has fluctuated between ₹ 281.50 and ₹ 291.00. Over the past year, NURECA LIMITED has achieved a return of 4.58 %. In the last month alone, the return has been 2.60 %. Read More...

Investment Returns

Over 1 Month 2.60% Over 3 Months 35.22% Over 6 Months -23.85% Over 1 Year 4.58%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NURECA LIMITED fundamentals


  • Market cap (Cr)

    286.70

  • P/E Ratio (TTM)

    -423.13

  • Beta

    0.67

  • Book Value / share

    192.47

  • Return on equity

    -0.35%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.07

info icon alternate text
  • Market cap (Cr)

    283.50

  • P/E Ratio (TTM)

    -423.13

  • Beta

    0.56

  • Book Value / share

    192.47

  • Return on equity

    -0.35%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.07

info icon alternate text

NURECA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 31.75
Operating Expense 32.25
Net Profit 2.07
Net Profit Margin (%) 6.51
Earnings Per Share (EPS) 2.07
EBITDA 2.57
Effective Tax Rate (%) -37.99
Particulars DEC 2024 (Values in Cr)
Revenue 27.21
Operating Expense 32.57
Net Profit -3.29
Net Profit Margin (%) -12.09
Earnings Per Share (EPS) -3.29
EBITDA -3.21
Effective Tax Rate (%) 14.54
Particulars SEP 2024 (Values in Cr)
Revenue 32.37
Operating Expense 35.85
Net Profit -0.65
Net Profit Margin (%) -2.00
Earnings Per Share (EPS) -0.65
EBITDA 0.54
Effective Tax Rate (%) -140.74
Particulars JUN 2024 (Values in Cr)
Revenue 23.31
Operating Expense 26.97
Net Profit 1.20
Net Profit Margin (%) 5.14
Earnings Per Share (EPS) 1.19
EBITDA 2.90
Effective Tax Rate (%) 44.90
Particulars MAR 2024 (Values in Cr)
Revenue 19.56
Operating Expense 25.06
Net Profit -4.41
Net Profit Margin (%) -22.54
Earnings Per Share (EPS) -4.41
EBITDA -6.01
Effective Tax Rate (%) 34.56
Particulars MAR 2025 (Values in Cr)
Revenue 114.64
Operating Expense 127.65
Net Profit -0.67
Net Profit Margin (%) -0.58
Earnings Per Share (EPS) -0.67
EBITDA 2.81
Effective Tax Rate (%) -45.65
Particulars MAR 2024 (Values in Cr)
Revenue 94.52
Operating Expense 108.35
Net Profit -2.44
Net Profit Margin (%) -2.58
Earnings Per Share (EPS) -2.44
EBITDA -0.56
Effective Tax Rate (%) 25.38
Particulars MAR 2023 (Values in Cr)
Revenue 111.90
Operating Expense 130.02
Net Profit -8.42
Net Profit Margin (%) -7.52
Earnings Per Share (EPS) -8.40
EBITDA -8.23
Effective Tax Rate (%) 23.17
Particulars MAR 2022 (Values in Cr)
Revenue 255.55
Operating Expense 201.94
Net Profit 45.31
Net Profit Margin (%) 17.73
Earnings Per Share (EPS) 45.31
EBITDA 63.48
Effective Tax Rate (%) 26.12
Particulars MAR 2021 (Values in Cr)
Revenue 213.33
Operating Expense 153.66
Net Profit 46.53
Net Profit Margin (%) 21.81
Earnings Per Share (EPS) 62.25
EBITDA 64.50
Effective Tax Rate (%) 25.54
Particulars MAR 2025 (Values in Cr)
Book Value / Share 194.29
ROE % -1.12
ROCE % -0.89
Total Debt to Total Equity 0.02
EBITDA Margin 0.51
Particulars MAR 2024 (Values in Cr)
Book Value / Share 193.11
ROE % -3.14
ROCE % -4.00
Total Debt to Total Equity 0.02
EBITDA Margin -6.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 194.88
ROE % -5.37
ROCE % -6.26
Total Debt to Total Equity 0.02
EBITDA Margin -9.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 203.20
ROE % 24.55
ROCE % 32.88
Total Debt to Total Equity 0.02
EBITDA Margin 24.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.10
ROE % 52.09
ROCE % 66.51
Total Debt to Total Equity 0.08
EBITDA Margin 30.15
Particulars MAR 2025 (Values in Cr)
Book Value / Share 192.48
ROE % -0.35
ROCE % 0.34
Total Debt to Total Equity 0.02
EBITDA Margin 2.45
Particulars MAR 2024 (Values in Cr)
Book Value / Share 192.86
ROE % -1.26
ROCE % -1.42
Total Debt to Total Equity 0.01
EBITDA Margin -0.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 195.26
ROE % -4.22
ROCE % -5.16
Total Debt to Total Equity 0.02
EBITDA Margin -7.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 203.74
ROE % 24.69
ROCE % 33.01
Total Debt to Total Equity 0.02
EBITDA Margin 24.84
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.29
ROE % 52.20
ROCE % 66.65
Total Debt to Total Equity 0.08
EBITDA Margin 30.23
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 46.25
Total Assets 209.97
Total Liabilities 209.97
Total Equity 194.28
Share Outstanding 10000175
Price to Book Ratio 1.09
Return on Assets (%) 0.40
Return on Capital (%) 0.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 45.30
Total Assets 205.16
Total Liabilities 205.16
Total Equity 193.11
Share Outstanding 10000175
Price to Book Ratio 1.32
Return on Assets (%) -0.87
Return on Capital (%) -0.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.96
Total Assets 206.58
Total Liabilities 206.58
Total Equity 194.88
Share Outstanding 10000175
Price to Book Ratio 1.54
Return on Assets (%) -3.99
Return on Capital (%) -4.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 84.35
Total Assets 219.13
Total Liabilities 219.13
Total Equity 203.19
Share Outstanding 10000175
Price to Book Ratio 6.69
Return on Assets (%) 20.51
Return on Capital (%) 22.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 126.69
Total Assets 185.75
Total Liabilities 185.75
Total Equity 163.09
Share Outstanding 10000175
Price to Book Ratio 3.69
Return on Assets (%) 24.96
Return on Capital (%) 28.26
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 46.20
Total Assets 206.15
Total Liabilities 206.15
Total Equity 192.47
Share Outstanding 10000175
Price to Book Ratio 1.09
Return on Assets (%) -0.32
Return on Capital (%) -0.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 45.20
Total Assets 204.33
Total Liabilities 204.33
Total Equity 192.85
Share Outstanding 10000175
Price to Book Ratio 1.32
Return on Assets (%) -1.19
Return on Capital (%) -1.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.86
Total Assets 206.68
Total Liabilities 206.68
Total Equity 195.26
Share Outstanding 10000175
Price to Book Ratio 1.54
Return on Assets (%) -4.07
Return on Capital (%) -4.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 84.18
Total Assets 219.53
Total Liabilities 219.53
Total Equity 203.74
Share Outstanding 10000175
Price to Book Ratio 6.69
Return on Assets (%) 20.63
Return on Capital (%) 22.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 126.44
Total Assets 185.88
Total Liabilities 185.88
Total Equity 163.29
Share Outstanding 10000175
Price to Book Ratio 3.69
Return on Assets (%) 25.03
Return on Capital (%) 28.34
Particulars MAR 2025 (Values in Cr)
Net Income 1.34
Cash from Operations -17.70
Cash from Investing 8.43
Cash from Financing -0.16
Net change in Cash -10.81
Free Cash Flow -15.39
Particulars MAR 2024 (Values in Cr)
Net Income -2.54
Cash from Operations -3.96
Cash from Investing 17.57
Cash from Financing -1.30
Net change in Cash 13.56
Free Cash Flow -2.87
Particulars MAR 2023 (Values in Cr)
Net Income -10.74
Cash from Operations 14.37
Cash from Investing -16.45
Cash from Financing -1.50
Net change in Cash -7.73
Free Cash Flow 14.77
Particulars MAR 2022 (Values in Cr)
Net Income 60.98
Cash from Operations 19.35
Cash from Investing -3.08
Cash from Financing -7.30
Net change in Cash -8.99
Free Cash Flow 22.75
Particulars MAR 2021 (Values in Cr)
Net Income 62.33
Cash from Operations 49.93
Cash from Investing -110.04
Cash from Financing 92.34
Net change in Cash 17.16
Free Cash Flow 50.35
Particulars MAR 2025 (Values in Cr)
Net Income -0.46
Cash from Operations -17.51
Cash from Investing 8.56
Cash from Financing -0.78
Net change in Cash -10.77
Free Cash Flow -15.53
Particulars MAR 2024 (Values in Cr)
Net Income -3.26
Cash from Operations -4.48
Cash from Investing 17.83
Cash from Financing -1.27
Net change in Cash 13.56
Free Cash Flow -3.98
Particulars MAR 2023 (Values in Cr)
Net Income -10.95
Cash from Operations 16.18
Cash from Investing -18.30
Cash from Financing -1.50
Net change in Cash -7.75
Free Cash Flow 16.42
Particulars MAR 2022 (Values in Cr)
Net Income 61.33
Cash from Operations 19.78
Cash from Investing -3.36
Cash from Financing -7.30
Net change in Cash -8.84
Free Cash Flow 23.04
Particulars MAR 2021 (Values in Cr)
Net Income 62.49
Cash from Operations 50.16
Cash from Investing -110.48
Cash from Financing 92.33
Net change in Cash 16.96
Free Cash Flow 50.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
MSTC LIMITED 532.65 19.08 5.07 3749.86 410.80 / 1037.00
NIHAR INFO GLOBAL LTD. 5.55 0.00 0.96 5.78 4.01 / 7.47
INFO EDGE (I) LTD 1420.20 106.62 2.63 92017.68 1151.45 / 1838.99
INTRASOFT TECH. LTD 112.85 14.51 0.80 184.08 89.95 / 191.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
MSTC LIMITED 532.65 19.44 4.98 3749.86 410.80 / 1037.00
Mitshi India Limited 15.72 0.00 5.08 13.83 13.01 / 20.49
AVI PRODUCTS INDIA LIMITED 20.25 126.56 0.94 6.70 18.05 / 29.29
OLYMPIA INDUSTRIES LTD. 38.99 18.13 0.54 23.49 32.98 / 72.00

NURECA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
286.65 -1.12 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 288.80
  • 26 Days 279.80
  • 10 Days 286.80
  • 50 Days 271.40
  • 12 Days 285.90
  • 100 Days 267.50
  • 20 Days 282.50
  • 200 Days 275.70
297.17 PIVOT

First Support

279.73

First Resistance

307.33

Second Support

269.57

Second Resistance

324.77

Third Support

252.13

Third Resistance

334.93

RSI

57.50

ADX

14.54

MACD

6.50

Williams % R

-46.08

Commodity Channel Index (CCI)

181.79

Date

2025-04-09

Week

5436.00

Same Day

4058.00

Month

14118.00

1 Year

0.67

3 Year

0.64

Over 1 Month

2.60%

down

Over 1 Year

4.58%

down

Over 3 Months

35.22%

down

Over 3 Years

-33.78%

down

Over 6 Months

-23.85%

down

Over 5 Years

-14.80%

down

NURECA LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
34.58%
Promoter Holdings
64.3%
FII
1.07%
DII
0.03%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Saurabh Goyal 3186158.0 (31.86%) Shareholding of Promoter and Promoter Group
Payal Goyal 2459928.0 (24.6%) Shareholding of Promoter and Promoter Group
Aryan Goyal 723353.0 (7.23%) Shareholding of Promoter and Promoter Group
Nisarg Vakharia 178000.0 (1.78%) Public Shareholding
Nectar Biopharma Private Limited 60842.0 (0.61%) Shareholding of Promoter and Promoter Group
Smita Goyal 7.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

NURECA LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Feb 2022 3.0 Interim 25 Feb 2022 Equity shares
21 Sep 2021 2.0 Final 23 Sep 2021 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

NURECA LIMITED Share Price

Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited.

Nureca is a digitally native, consumer healthcare company with a leading presence in categories such as home diagnostics, wellness devices, and personal fitness equipment under brands like Dr Trust and Dr Physio. The Company's differentiated strategy is built around four pillars: Product Innovation, Omnichannel Distribution, Direct-to-Consumer (D2C) Excellence and In-House Manufacturing Capabilities.

The Company is engaged in the business of home healthcare and wellness products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives.

In 2017, the Company commenced business operations and launched 'Dr. Trust' brand through digital healthcare channel.

In 2018, the Company widened product basket with launching of brands in electric massages and mother & child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh.

In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Company's key products secured a warehouse drug license.

In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores.

The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited and the Company and their respective shareholders and creditors and the Scheme became effective on 23 May 2020. Pursuant to Scheme of Demerger, certain portion of business activities of Nectar Biopharma Private Limited was transferred by Nectar Biopharma Private Limited from 01 April, 2019.

Nureca Technologies Private Limited have received industrial policy approval to establish a health and wellness equipment manufacturing plant at Village Sundra, SAS Nagar, Punjab in FY 25.

Parent organization Indian Private
NSE symbol NURECA
Founded 2016
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nureca Ltd?

Answer Field

Nureca Ltd share price is for NSE ₹ 286.90 & for BSE ₹ 287.95 as on Jul 11 2025 03:29 PM.

What is the Market Cap of Nureca Ltd Share?

Answer Field

The market cap of Nureca Ltd for NSE ₹ 286.90 & for BSE ₹ 287.95 as on Jul 11 2025 03:29 PM.

What is the 52 Week High and Low of Nureca Ltd?

Answer Field

The 52 Week High and Low of Nureca Ltd for NSE is ₹ 447.50 and ₹ 203.62 and for BSE is ₹ 447.00 and ₹ 198.00.

What is 1 year return for Nureca Ltd?

Answer Field

The 1 year returns on the stock has been 3.48%.

What is the P/E Ratio of Nureca Ltd Share?

Answer Field

As on Jul 11 2025 03:29 PM the price-to-earnings (PE) ratio for Nureca Ltd share is -423.13.

What is the PB ratio of Nureca Ltd Share?

Answer Field

As on Jul 11 2025 03:29 PM, the price-to-book (PB) ratio for Nureca Ltd share is 192.47.

How to Buy Nureca Ltd Share?

Answer Field

You can trade in Nureca Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nureca Ltd Share on Bajaj Broking App?

Answer Field

To buy Nureca Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nureca Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|